etoposide has been researched along with Encephalopathy, Toxic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Kuhn, AK; Rubin, MF | 1 |
| Bleckmann, K; Borkhardt, A; Bronsema, A; Burkhardt, B; Chen-Santel, C; Debatin, KM; Ebinger, M; Eckert, C; Escherich, G; Klingebiel, T; Kolb, R; Koscielniak, E; Kuhlen, M; Möricke, A; Queudeville, M; Rossig, C; Schrappe, M; Vieth, S; von Stackelberg, A; Vonalt, A; Zwaan, CM | 1 |
| Ayarza, M; Clark, SM; Hairston, A; Lentz, KL; Liu, B; Morgan, KP; Wind, LS | 1 |
| Al-Rubai, AJ; Grabowska, AM; Ivanov, DP; Pratten, MK | 1 |
| Jarkowski, A | 1 |
| Acquati, M; Ardizzoia, A; Casartelli, C; Fagnani, D; Fusco, O; Giordano, M; Malugani, F; Quattrone, A; Scanni, A; Tagliabue, P; Vergani, C; Visini, M | 1 |
| Brevet, M; Damaj, G; Garidi, R; Gruson, B; Royer, B; Vaida, I | 1 |
| Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R | 1 |
| Fortin, D; McCormick, CI; Neuwelt, EA; Nixon, R; Remsen, LG | 1 |
4 trial(s) available for etoposide and Encephalopathy, Toxic
| Article | Year |
|---|---|
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Neurotoxicity Syndromes; Retrospective Studies; T-Lymphocytes | 2017 |
Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophagitis; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Premedication; Remission Induction; Stomatitis; Survival Rate; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2004 |
First-line autologous stem cell transplantation in primary CNS lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompetence; Lymphoma; Male; Melphalan; Middle Aged; Neurotoxicity Syndromes; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Survival Rate; Transplantation, Autologous | 2005 |
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine | 2007 |
5 other study(ies) available for etoposide and Encephalopathy, Toxic
| Article | Year |
|---|---|
Management of methotrexate-induced neurotoxicity with aminophylline plus dextromethorphan in a pediatric patient with pineoblastoma.
Topics: Adolescent; Aminophylline; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bronchodilator Agents; Cisplatin; Cyclophosphamide; Dextromethorphan; Disease Management; Drug Therapy, Combination; Etoposide; Excitatory Amino Acid Antagonists; Female; Humans; Methotrexate; Neurotoxicity Syndromes; Pineal Gland; Pinealoma; Prognosis | 2020 |
Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cohort Studies; Etoposide; Female; Humans; Ifosfamide; Incidence; Lymphoma; Male; Middle Aged; Neurotoxicity Syndromes; Retrospective Studies; Thiamine | 2020 |
Separating chemotherapy-related developmental neurotoxicity from cytotoxicity in monolayer and neurosphere cultures of human fetal brain cells.
Topics: Antineoplastic Agents; Astrocytes; Brain; Cell Count; Cell Culture Techniques; Cell Survival; Cells, Cultured; Etoposide; Fetus; Glial Fibrillary Acidic Protein; Humans; Methylmercury Compounds; Neurons; Neurotoxicity Syndromes; Oxazines; Oxidation-Reduction; Spheroids, Cellular; Teniposide; Tubulin; Xanthenes | 2016 |
Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carboplatin; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Male; Morpholines; Nausea; Nerve Sheath Neoplasms; Neurotoxicity Syndromes | 2008 |
Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model.
Topics: Anesthesia, General; Anesthetics, Intravenous; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Disease Models, Animal; Etoposide; Female; Neurotoxicity Syndromes; Organophosphate Poisoning; Organophosphorus Compounds; Propofol; Rats; Rats, Long-Evans | 2000 |